Purple Biotech (PPBT) Enterprise Value Growth (3y) (2017 - 2026)
Purple Biotech (PPBT) Enterprise Value Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Purple Biotech | 1.33 Bn | 1.33 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.02% |
| Dec 31, 2025 | 14.25% |
| Sep 30, 2025 | 31.83% |
| Jun 30, 2025 | 46.27% |
| Mar 31, 2025 | 44.91% |
| Dec 31, 2024 | 71.62% |
| Sep 30, 2024 | 48.36% |
| Jun 30, 2024 | 46.63% |
| Mar 31, 2024 | 41.98% |
| Dec 31, 2023 | 35.73% |
| Jun 30, 2023 | 34.11% |
| Dec 31, 2022 | -36.95% |
| Jun 30, 2022 | -69.34% |
| Dec 31, 2021 | -96.30% |
| Jun 30, 2021 | -61.97% |
| Dec 31, 2020 | -110.54% |
| Jun 30, 2020 | -114.93% |
| Dec 31, 2019 | 25.97% |
| Jun 30, 2019 | 4.40% |
| Dec 31, 2018 | 16.25% |